KRS Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,941
| Closed | -$2.85M | – | 117 |
|
|
2023
Q2 | $2.85M | Sell |
27,941
-200
| -0.7% | -$20.4K | 2.85% | 5 |
|
|
2023
Q1 | $2.56M | Hold |
28,141
| – | – | 2.88% | 5 |
|
|
2022
Q4 | $1.07M | Hold |
28,141
| – | – | 1.46% | 14 |
|
|
2022
Q3 | $707K | Hold |
28,141
| – | – | 0.97% | 25 |
|
|
2022
Q2 | $855K | Hold |
28,141
| – | – | 1.22% | 20 |
|
|
2022
Q1 | $921K | Sell |
28,141
-4,700
| -14% | -$154K | 1% | 25 |
|
|
2021
Q4 | $866K | Buy |
+32,841
| New | +$866K | 0.74% | 29 |
|